Blood Neoplasia provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations that focus on hematologic malignancies and associated disorders – including leukemia, lymphoma, multiple myeloma, Waldenström macroglobulinemia, hemophagocytic lymphohistiocytosis, myeloproliferative neoplasms, minimal residual disease, and precursor conditions. All articles undergo a rigorous peer review. They are selected based on the originality of the findings, the superior quality of the work described, the clarity of presentation, and the expected impact on patient care.
Submit by August 31, 2024 and pay NO SUBMISSION FEE.